Trading Experts Call It “The Perfect Tesla Trade”

Thanks to a new discovery linked to shares of Tesla, regular folks can now target gains of 100% or more in six days or less. New research shows it’s happened 23 different times this year. The next trade is scheduled for this Thursday.

BMEA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 26.27%

Insider Buying (Last 12 Months): $12,000,000.00

Insider Selling (Last 12 Months): $12,604,750.00

Biomea Fusion Insider Trading History Chart

Biomea Fusion Share Price & Price History

^$16.89

▲ +1.86 (12.38%)

As of 12/8/2023 09:56 PM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

Invest in Autonomix today.

Biomea Fusion Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/31/2023	A2a Pharmaceuticals, Inc.	Major Shareholder	Sell	75,000	$33.81	$2,535,750.00	3,550,000
5/12/2023	A2a Pharmaceuticals, Inc.	Major Shareholder	Sell	25,000	$33.84	$846,000.00	3,625,000
5/8/2023	A2a Pharmaceuticals, Inc.	Major Shareholder	Sell	100,000	$33.99	$3,399,000.00	3,800,000
4/20/2023	A2a Pharmaceuticals, Inc.	Major Shareholder	Sell	200,000	$29.12	$5,824,000.00	3,900,000
3/30/2023	Bihua Chen	Director	Buy	400,000	$30.00	$12,000,000.00	3,570,872
11/14/2022	Michael J.M. Hitchcock	Director	Buy	5,000	$7.93	$39,650.00	5,000
7/21/2022	A2a Pharmaceuticals, Inc.	Major Shareholder	Sell	34,658	$11.21	$388,516.18	4,330,684
6/24/2022	A2a Pharmaceuticals, Inc.	Major Shareholder	Sell	34,658	$11.76	$407,578.08	4,365,342
1/14/2022	Franco Valle	CFO	Buy	10,000	$8.68	$86,800.00
9/17/2021	A2a Pharmaceuticals, Inc.	Major Shareholder	Buy	34,658	$10.96	$379,851.68
8/23/2021	Rainer M. Erdtmann	COO	Buy	24,000	$13.20	$316,800.00	76,059
8/17/2021	Rainer M. Erdtmann	COO	Buy	14,000	$10.79	$151,060.00	310,736
4/15/2021	Rainer M. Erdtmann	COO	Buy	176,470	$17.00	$2,999,990.00

New CBOE “special perk” helps traders target income every weekend

From DTI Trader | Ad

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

Check out this training for the full story!

SEC Filings (Institutional Ownership Changes) for Biomea Fusion (NASDAQ:BMEA)

93.68% of Biomea Fusion stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Biomea Fusion Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/6/2023	Citigroup Inc.	116,134	$1.60M	0.0%	+113.8%	0.325%
11/24/2023	Deutsche Bank AG	11,174	$0.15M	0.0%	+28.3%	0.031%
11/15/2023	GSA Capital Partners LLP	41,048	$0.57M	0.0%	+16.8%	0.115%
11/15/2023	Rock Springs Capital Management LP	181,147	$2.49M	0.1%	-78.4%	0.507%
11/15/2023	Laurion Capital Management LP	2,613,135	$35.96M	0.2%	+16.5%	7.318%
11/15/2023	Adage Capital Partners GP L.L.C.	180,000	$2.48M	0.0%	+125.0%	0.504%
11/15/2023	AQR Capital Management LLC	10,622	$0.15M	0.0%	-15.0%	0.030%
11/14/2023	Corton Capital Inc.	11,064	$0.15M	0.1%	N/A	0.031%
11/14/2023	California State Teachers Retirement System	24,724	$0.34M	0.0%	-7.8%	0.069%
11/14/2023	Tower Research Capital LLC TRC	3,251	$45K	0.0%	+316.3%	0.009%
11/14/2023	Trexquant Investment LP	31,573	$0.43M	0.0%	N/A	0.088%
11/14/2023	Profund Advisors LLC	38,890	$0.54M	0.0%	+57.4%	0.109%
11/13/2023	Northern Trust Corp	185,155	$2.55M	0.0%	+2.2%	0.518%
11/13/2023	Invesco Ltd.	18,024	$0.25M	0.0%	-92.8%	0.050%
11/13/2023	FMR LLC	5,344,191	$73.54M	0.0%	+0.6%	14.966%
11/13/2023	Rafferty Asset Management LLC	233,848	$3.22M	0.0%	+70.8%	0.655%
11/13/2023	E Fund Management Co. Ltd.	12,010	$0.17M	0.0%	N/A	0.034%
11/9/2023	Deutsche Bank AG	11,174	$0.15M	0.0%	+28.3%	0.031%
11/9/2023	Citigroup Inc.	116,134	$1.60M	0.0%	+113.8%	0.325%
11/9/2023	UBS Group AG	55,800	$0.77M	0.0%	+56.8%	0.156%
11/8/2023	Charles Schwab Investment Management Inc.	174,428	$2.40M	0.0%	+214.7%	0.488%
11/7/2023	Barclays PLC	116,621	$1.61M	0.0%	+73.7%	0.327%
11/7/2023	Jump Financial LLC	42,716	$0.59M	0.0%	-55.3%	0.120%
10/26/2023	Mirae Asset Global Investments Co. Ltd.	17,804	$0.25M	0.0%	+19.2%	0.050%
10/25/2023	Zurcher Kantonalbank Zurich Cantonalbank	4,744	$65K	0.0%	+89.6%	0.013%
10/18/2023	Exchange Traded Concepts LLC	6,903	$95K	0.0%	+93.1%	0.019%
8/24/2023	Perceptive Advisors LLC	716,441	$15.73M	0.5%	+120.4%	2.011%
8/21/2023	California State Teachers Retirement System	26,829	$0.59M	0.0%	N/A	0.075%
8/21/2023	Osaic Holdings Inc.	9,859	$0.22M	0.0%	N/A	0.028%
8/16/2023	GTS Securities LLC	17,168	$0.38M	0.0%	N/A	0.048%
8/15/2023	Alliancebernstein L.P.	19,660	$0.43M	0.0%	N/A	0.055%
8/15/2023	Wells Fargo & Company MN	31,624	$0.69M	0.0%	+15,251.5%	0.089%
8/15/2023	Royal Bank of Canada	8,233	$0.18M	0.0%	+7,741.0%	0.023%
8/15/2023	HighVista Strategies LLC	37,600	$0.83M	0.4%	N/A	0.106%
8/14/2023	Schonfeld Strategic Advisors LLC	22,369	$0.49M	0.0%	N/A	0.063%
8/14/2023	ArrowMark Colorado Holdings LLC	76,285	$1.67M	0.0%	+6.0%	0.214%
8/14/2023	State of Wisconsin Investment Board	25,816	$0.57M	0.0%	N/A	0.072%
8/14/2023	Artia Global Partners LP	25,452	$0.56M	0.2%	N/A	0.071%
8/14/2023	State Street Corp	1,567,950	$34.42M	0.0%	+2,684.2%	4.401%
8/14/2023	UniSuper Management Pty Ltd	200,256	$4.40M	0.0%	N/A	0.562%
8/14/2023	Rock Springs Capital Management LP	836,898	$18.37M	0.4%	-35.5%	2.349%
8/14/2023	Nuveen Asset Management LLC	55,075	$1.21M	0.0%	N/A	0.155%
8/14/2023	Driehaus Capital Management LLC	1,178,471	$25.87M	0.3%	+38.7%	3.308%
8/14/2023	Polar Capital Holdings Plc	250,000	$5.49M	0.0%	-57.3%	0.702%
8/11/2023	Nan Fung Group Holdings Ltd	40,000	$0.88M	0.6%	-33.3%	0.112%
8/11/2023	Credit Suisse AG	31,169	$0.68M	0.0%	N/A	0.087%
8/11/2023	BlackRock Inc.	1,961,189	$43.05M	0.0%	+100.0%	5.504%
8/11/2023	Ameritas Investment Partners Inc.	1,641	$36K	0.0%	N/A	0.005%
8/11/2023	The Manufacturers Life Insurance Company	12,167	$0.27M	0.0%	N/A	0.034%
8/11/2023	Geode Capital Management LLC	430,296	$9.45M	0.0%	+102.7%	1.208%
8/11/2023	Northern Trust Corp	181,088	$3.98M	0.0%	+480.3%	0.508%
8/10/2023	MetLife Investment Management LLC	10,646	$0.23M	0.0%	N/A	0.030%
8/10/2023	Osaic Holdings Inc.	9,859	$0.22M	0.0%	N/A	0.028%
8/10/2023	Profund Advisors LLC	24,713	$0.54M	0.0%	N/A	0.069%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	14,932	$0.33M	0.0%	N/A	0.042%
8/10/2023	Cetera Advisors LLC	15,430	$0.34M	0.0%	N/A	0.043%
8/10/2023	Charles Schwab Investment Management Inc.	55,427	$1.22M	0.0%	+621.7%	0.156%
8/10/2023	Citigroup Inc.	54,324	$1.19M	0.0%	+18.2%	0.152%
8/9/2023	Dimensional Fund Advisors LP	76,926	$1.69M	0.0%	-14.7%	0.216%
8/9/2023	Swiss National Bank	50,100	$1.10M	0.0%	N/A	0.141%
8/8/2023	Rhumbline Advisers	27,398	$0.60M	0.0%	N/A	0.077%
8/4/2023	American International Group Inc.	9,562	$0.21M	0.0%	N/A	0.027%
8/3/2023	Barclays PLC	67,136	$1.47M	0.0%	+627.4%	0.188%
8/3/2023	Bank of New York Mellon Corp	70,171	$1.54M	0.0%	+362.8%	0.197%
8/3/2023	Oppenheimer & Co. Inc.	12,044	$0.26M	0.0%	N/A	0.034%
7/25/2023	DekaBank Deutsche Girozentrale	40,000	$0.87M	0.0%	+33.3%	0.113%
7/20/2023	Exchange Traded Concepts LLC	3,574	$78K	0.0%	N/A	0.010%
5/18/2023	JPMorgan Chase & Co.	164,899	$5.11M	0.0%	-17.5%	0.467%
5/16/2023	Perceptive Advisors LLC	325,000	$10.08M	0.3%	N/A	0.920%
5/16/2023	CVI Holdings LLC	70,000	$2.17M	0.8%	N/A	0.198%
5/16/2023	State Street Corp	56,315	$1.75M	0.0%	+8.9%	0.159%
5/16/2023	Sandia Investment Management LP	10,000	$0.31M	0.1%	N/A	0.028%
5/16/2023	Fred Alger Management LLC	16,689	$0.52M	0.0%	N/A	0.047%
5/16/2023	Geode Capital Management LLC	212,285	$6.58M	0.0%	+30.8%	0.601%
5/16/2023	Gilder Gagnon Howe & Co. LLC	10,139	$0.31M	0.0%	N/A	0.029%
5/16/2023	Ghisallo Capital Management LLC	20,000	$0.62M	0.1%	N/A	0.057%
5/16/2023	ArrowMark Colorado Holdings LLC	72,000	$2.23M	0.0%	N/A	0.204%
5/16/2023	Baker BROS. Advisors LP	2,108,949	$65.40M	0.4%	+0.2%	5.973%
5/16/2023	Balyasny Asset Management L.P.	7,695	$0.24M	0.0%	-26.2%	0.022%
5/15/2023	Two Sigma Investments LP	19,916	$0.62M	0.0%	+23.5%	0.056%
5/15/2023	Ghost Tree Capital LLC	120,000	$3.72M	1.1%	N/A	0.340%
5/12/2023	Renaissance Technologies LLC	79,800	$2.48M	0.0%	+26.7%	0.226%
5/12/2023	Cresset Asset Management LLC	12,500	$0.39M	0.0%	N/A	0.035%
5/12/2023	BlackRock Inc.	980,834	$30.42M	0.0%	+78.7%	2.778%
5/12/2023	HRT Financial LP	75,510	$2.34M	0.0%	+241.4%	0.214%
5/12/2023	Sei Investments Co.	12,705	$0.39M	0.0%	N/A	0.036%
5/12/2023	Dimensional Fund Advisors LP	90,146	$2.80M	0.0%	+4.6%	0.255%
5/12/2023	Charles Schwab Investment Management Inc.	7,680	$0.24M	0.0%	N/A	0.022%
5/11/2023	FMR LLC	2,673,022	$82.89M	0.0%	+556.4%	7.570%
5/11/2023	Citigroup Inc.	45,971	$1.43M	0.0%	+22.0%	0.130%
5/9/2023	Tower Research Capital LLC TRC	1,918	$59K	0.0%	-31.1%	0.005%
5/9/2023	Bank of New York Mellon Corp	15,161	$0.47M	0.0%	N/A	0.043%
5/5/2023	Monashee Investment Management LLC	90,000	$2.79M	0.8%	N/A	0.255%
5/4/2023	Barclays PLC	9,229	$0.29M	0.0%	-9.6%	0.027%
4/24/2023	DekaBank Deutsche Girozentrale	30,000	$0.96M	0.0%	N/A	0.101%
4/20/2023	High Net Worth Advisory Group LLC	7,500	$0.23M	0.1%	+650.0%	0.025%
4/14/2023	Raymond James Financial Services Advisors Inc.	7,982	$0.25M	0.0%	N/A	0.027%
4/14/2023	Chartwell Investment Partners LLC	8,311	$0.26M	0.0%	N/A	0.028%
2/15/2023	Millennium Management LLC	131,374	$1.11M	0.0%	-14.6%	0.447%
2/15/2023	Morgan Stanley	116,204	$0.98M	0.0%	+12.6%	0.395%

Data available starting January 2016

Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.

Today's Range

Now: $16.89

$10.35

$17.15

50 Day Range

MA: $11.53

$8.37

$19.80

52 Week Range

Now: $16.89

$6.04

$43.69

Volume

6,633,200 shs

Average Volume

733,440 shs

Market Capitalization

$603.07 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Biomea Fusion?: Biomea Fusion's top insider investors include:
A2a Pharmaceuticals, Inc (Major Shareholder)
Bihua Chen (Director)
Michael JM Hitchcock (Director)
Franco Valle (CFO)
Learn More about top insider investors at Biomea Fusion.
Who are the major institutional investors of Biomea Fusion?: Biomea Fusion's top institutional investors include:
FMR LLC — 14.97%
Laurion Capital Management LP — 7.32%
Rafferty Asset Management LLC — 0.65%
Northern Trust Corp — 0.52%
Rock Springs Capital Management LP — 0.51%
Adage Capital Partners GP L.L.C. — 0.50%
Learn More about top institutional investors of Biomea Fusion stock.
Which major investors are selling Biomea Fusion stock?: In the previous quarter, BMEA stock was sold by these institutional investors:
Rock Springs Capital Management LP
Invesco Ltd.
Jump Financial LLC
HAP Trading LLC
Belvedere Trading LLC
California State Teachers Retirement System
AQR Capital Management LLC
Which major investors are buying Biomea Fusion stock?: During the last quarter, BMEA stock was bought by institutional investors including:
Laurion Capital Management LP
Charles Schwab Investment Management Inc.
Adage Capital Partners GP L.L.C.
Rafferty Asset Management LLC
Citigroup Inc.
Citigroup Inc.
Barclays PLC
FMR LLC
In the last year, these company insiders have bought Biomea Fusion stock:
A2a Pharmaceuticals, Inc (Major Shareholder)
Bihua Chen (Director)
Michael JM Hitchcock (Director)
Learn More investors buying Biomea Fusion stock.